The University of Chicago Header Logo

Connection

John Fung to Child

This is a "connection" page, showing publications John Fung has written about Child.
Connection Strength

0.765
  1. Liver transplantation for nonalcoholic steatohepatitis in young patients. Transpl Int. 2016 Apr; 29(4):418-24.
    View in: PubMed
    Score: 0.060
  2. [Analysis of causes of late mortality in liver transplant recipients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Sep; 16(9):547-51.
    View in: PubMed
    Score: 0.027
  3. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209.
    View in: PubMed
    Score: 0.025
  4. Living donor liver transplantation: ethics and safety. Transplant Proc. 2003 Feb; 35(1):51-2.
    View in: PubMed
    Score: 0.024
  5. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
    View in: PubMed
    Score: 0.023
  6. Highlights of the Festschrift in honor of Thomas E. Starzl, MD, PHD. Am J Transplant. 2002 Jan; 2(1):7-11.
    View in: PubMed
    Score: 0.022
  7. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg. 2000 Oct; 232(4):490-500.
    View in: PubMed
    Score: 0.020
  8. Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg. 2000 Feb; 35(2):283-9; discussion 289-90.
    View in: PubMed
    Score: 0.019
  9. Tc-99m hexamethylpropylene amine oxime scintigraphy in the diagnosis of brain death and its implications for the harvesting of organs used for transplantation. Clin Nucl Med. 2000 Jan; 25(1):7-10.
    View in: PubMed
    Score: 0.019
  10. Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience. J Gastrointest Surg. 2019 11; 23(11):2201-2210.
    View in: PubMed
    Score: 0.018
  11. Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc. 1998 Jun; 30(4):1403-4.
    View in: PubMed
    Score: 0.017
  12. Split liver transplantation in adults. World J Gastroenterol. 2016 Sep 07; 22(33):7500-6.
    View in: PubMed
    Score: 0.015
  13. Role of Doppler Sonography in Early Detection of Splenic Steal Syndrome. J Ultrasound Med. 2016 Jul; 35(7):1393-400.
    View in: PubMed
    Score: 0.015
  14. Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi-blinded prospective randomized trial. Clin Transplant. 2015 Dec; 29(12):1173-80.
    View in: PubMed
    Score: 0.014
  15. Hepatic artery angioplasty after liver transplantation: experience in 21 allografts. J Vasc Interv Radiol. 1995 Jul-Aug; 6(4):523-9.
    View in: PubMed
    Score: 0.014
  16. FK 506 in solid organ transplantation. Transplant Proc. 1994 Oct; 26(5):3017-20.
    View in: PubMed
    Score: 0.013
  17. Split liver transplantation using Hemiliver graft in the MELD era: a single center experience in the United States. Am J Transplant. 2014 Sep; 14(9):2072-80.
    View in: PubMed
    Score: 0.013
  18. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation. 1994 Mar 27; 57(6):860-5.
    View in: PubMed
    Score: 0.013
  19. Early clinical and histologic viability of human liver-small intestinal allografts after implantation. Clin Transplant. 1994 Feb; 8(1):49-53.
    View in: PubMed
    Score: 0.013
  20. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol. 1994; 2(1):61-7.
    View in: PubMed
    Score: 0.013
  21. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993 Jun; 17(6):1127-52.
    View in: PubMed
    Score: 0.012
  22. The many faces of multivisceral transplantation. Surg Gynecol Obstet. 1991 May; 172(5):335-44.
    View in: PubMed
    Score: 0.011
  23. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc. 1990 Feb; 22(1):6-12.
    View in: PubMed
    Score: 0.010
  24. Overview of FK506 in transplantation. Clin Transpl. 1990; 115-21.
    View in: PubMed
    Score: 0.010
  25. Liver transplantation at Cleveland Clinic. Clin Transpl. 2010; 195-206.
    View in: PubMed
    Score: 0.010
  26. Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc. 1987 Apr; 19(2 Suppl 1):37-44.
    View in: PubMed
    Score: 0.008
  27. Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron. 1987; 46 Suppl 1:19-33.
    View in: PubMed
    Score: 0.008
  28. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transpl Int. 2006 Jan; 19(1):27-37.
    View in: PubMed
    Score: 0.007
  29. Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology. 2004 Sep-Oct; 51(59):1413-6.
    View in: PubMed
    Score: 0.007
  30. Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. Transplant Proc. 2004 Sep; 36(7):1955-8.
    View in: PubMed
    Score: 0.007
  31. De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004 Jun 15; 77(11):1719-25.
    View in: PubMed
    Score: 0.007
  32. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation. 2003 Apr 15; 75(7):1020-5.
    View in: PubMed
    Score: 0.006
  33. Pancreatitis after liver transplantation in children: a single-center experience. Transplantation. 2003 Jan 27; 75(2):190-3.
    View in: PubMed
    Score: 0.006
  34. Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc. 2002 Aug; 34(5):1955-7.
    View in: PubMed
    Score: 0.006
  35. Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. Transplant Proc. 2002 Aug; 34(5):1968-9.
    View in: PubMed
    Score: 0.006
  36. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002 Mar 27; 73(6):941-7.
    View in: PubMed
    Score: 0.006
  37. Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today. 2002; 32(9):792-9.
    View in: PubMed
    Score: 0.006
  38. Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatr Transplant. 2001 Oct; 5(5):359-64.
    View in: PubMed
    Score: 0.005
  39. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation. 2001 Sep 15; 72(5):851-5.
    View in: PubMed
    Score: 0.005
  40. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 2001 Feb-Mar; 33(1-2):1235-6.
    View in: PubMed
    Score: 0.005
  41. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000 Oct; 191(4):389-94.
    View in: PubMed
    Score: 0.005
  42. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 2000 Sep 15; 70(5):760-4.
    View in: PubMed
    Score: 0.005
  43. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J Biol Chem. 2000 Sep 08; 275(36):28083-92.
    View in: PubMed
    Score: 0.005
  44. The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc. 2000 Sep; 32(6):1197-8.
    View in: PubMed
    Score: 0.005
  45. Bacterial translocation in clinical intestinal transplantation. Transplant Proc. 2000 Sep; 32(6):1210.
    View in: PubMed
    Score: 0.005
  46. Posttransplant lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc. 2000 Sep; 32(6):1213.
    View in: PubMed
    Score: 0.005
  47. The long-term efficacy of multivisceral transplantation. Transplant Proc. 2000 Sep; 32(6):1219-20.
    View in: PubMed
    Score: 0.005
  48. Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc. 2000 Sep; 32(6):1223-4.
    View in: PubMed
    Score: 0.005
  49. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology. 2000 Mar; 31(3):577-80.
    View in: PubMed
    Score: 0.005
  50. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999 Dec 27; 68(12):1851-4.
    View in: PubMed
    Score: 0.005
  51. An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1999 Sep 15; 68(5):650-5.
    View in: PubMed
    Score: 0.005
  52. Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg. 1999 Apr-Jun; 62(2):244-7.
    View in: PubMed
    Score: 0.005
  53. Posttransplant diabetes in pediatric recipients on tacrolimus. Transplantation. 1999 Mar 15; 67(5):771.
    View in: PubMed
    Score: 0.005
  54. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999 Feb 15; 67(3):411-5.
    View in: PubMed
    Score: 0.005
  55. Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder. Transplant Proc. 1999 Feb-Mar; 31(1-2):488-9.
    View in: PubMed
    Score: 0.005
  56. Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation. 1999 Jan 27; 67(2):299-303.
    View in: PubMed
    Score: 0.005
  57. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1998 Oct 27; 66(8):1047-52.
    View in: PubMed
    Score: 0.004
  58. Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc. 1998 Jun; 30(4):1257-60.
    View in: PubMed
    Score: 0.004
  59. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May; 186(5):512-25; discussion 525-7.
    View in: PubMed
    Score: 0.004
  60. HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation. 1997 Oct 15; 64(7):983-91.
    View in: PubMed
    Score: 0.004
  61. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997 Oct; 26(4):877-83.
    View in: PubMed
    Score: 0.004
  62. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology. 1997 Aug; 26(2):444-50.
    View in: PubMed
    Score: 0.004
  63. Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):310.
    View in: PubMed
    Score: 0.004
  64. Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1174-7.
    View in: PubMed
    Score: 0.004
  65. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation. 1997 Jan 27; 63(2):223-8.
    View in: PubMed
    Score: 0.004
  66. Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997 Jan 27; 63(2):243-9.
    View in: PubMed
    Score: 0.004
  67. Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int. 1997; 10(2):133-6.
    View in: PubMed
    Score: 0.004
  68. Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc. 1996 Oct; 28(5):2757-8.
    View in: PubMed
    Score: 0.004
  69. Tacrolimus in renal transplantation. Transplant Proc. 1996 Aug; 28(4):2117-8.
    View in: PubMed
    Score: 0.004
  70. One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc. 1995 Feb; 27(1):1099-104.
    View in: PubMed
    Score: 0.003
  71. Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995 Feb; 27(1):710-2.
    View in: PubMed
    Score: 0.003
  72. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation. 1995 Jan 27; 59(2):212-7.
    View in: PubMed
    Score: 0.003
  73. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995 Jan; 180(1):1-9.
    View in: PubMed
    Score: 0.003
  74. Three years clinical experience with intestinal transplantation. J Am Coll Surg. 1994 Oct; 179(4):385-400.
    View in: PubMed
    Score: 0.003
  75. Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg. 1994 Sep; 220(3):297-308; discussion 308-9.
    View in: PubMed
    Score: 0.003
  76. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg. 1994 Jan; 219(1):40-5.
    View in: PubMed
    Score: 0.003
  77. Posttransplant hypertension in blacks versus nonblacks. Transplant Proc. 1993 Aug; 25(4):2456-7.
    View in: PubMed
    Score: 0.003
  78. Clinical intestinal transplantation. Transplant Proc. 1993 Jun; 25(3):2195-7.
    View in: PubMed
    Score: 0.003
  79. Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet. 1993 Mar; 176(3):297-8.
    View in: PubMed
    Score: 0.003
  80. Two-year experience with FK 506 in pediatric patients. Transplant Proc. 1993 Feb; 25(1 Pt 1):619-21.
    View in: PubMed
    Score: 0.003
  81. Intestinal transplantation in humans under FK 506. Transplant Proc. 1993 Feb; 25(1 Pt 2):1198-9.
    View in: PubMed
    Score: 0.003
  82. Nutritional management of intestinal transplant recipients. Transplant Proc. 1993 Feb; 25(1 Pt 2):1200-1.
    View in: PubMed
    Score: 0.003
  83. Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. Transplant Proc. 1992 Dec; 24(6):3038-9.
    View in: PubMed
    Score: 0.003
  84. Management of intestinal transplantation in humans. Transplant Proc. 1992 Jun; 24(3):1243-4.
    View in: PubMed
    Score: 0.003
  85. Human islet allotransplantation in 18 diabetic patients. Transplant Proc. 1992 Jun; 24(3):961.
    View in: PubMed
    Score: 0.003
  86. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation. 1992 May; 53(5):1056-62.
    View in: PubMed
    Score: 0.003
  87. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation. 1992 Feb; 53(2):407-14.
    View in: PubMed
    Score: 0.003
  88. Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3044-6.
    View in: PubMed
    Score: 0.003
  89. Human islet allotransplantation under FK 506. Transplant Proc. 1991 Dec; 23(6):3207.
    View in: PubMed
    Score: 0.003
  90. FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc. 1991 Dec; 23(6):3225-7.
    View in: PubMed
    Score: 0.003
  91. Liver transplantation under cyclosporine: a decade of experience. Transplant Proc. 1991 Feb; 23(1 Pt 2):1393-6.
    View in: PubMed
    Score: 0.003
  92. Use of FK 506 in pediatric patients. Transplant Proc. 1991 Feb; 23(1 Pt 2):924-7.
    View in: PubMed
    Score: 0.003
  93. The liver transplant waiting list--a single-center analysis. Transplantation. 1991 Jan; 51(1):128-34.
    View in: PubMed
    Score: 0.003
  94. Liver transplantation in patients over sixty years of age. Transplantation. 1991 Jan; 51(1):271-3.
    View in: PubMed
    Score: 0.003
  95. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg. 1990 Sep; 212(3):295-305; discussion 306-7.
    View in: PubMed
    Score: 0.003
  96. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet. 1990 Aug 18; 336(8712):402-5.
    View in: PubMed
    Score: 0.003
  97. The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system. Clin Transpl. 1989; 287-93.
    View in: PubMed
    Score: 0.002
  98. Effect of OKT3 on survival and rate of retransplantation. Transplant Proc. 1987 Aug; 19(4 Suppl 3):61-2.
    View in: PubMed
    Score: 0.002
  99. OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc. 1987 Feb; 19(1 Pt 3):2443-6.
    View in: PubMed
    Score: 0.002
  100. Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron. 1987; 46 Suppl 1:56-9.
    View in: PubMed
    Score: 0.002
  101. The antibody crossmatch in liver transplantation. Surgery. 1986 Oct; 100(4):705-15.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.